Haleos Labs closes trading window from July 1 till Q1FY27 results
Haleos Labs Limited has closed its trading window for designated persons from July 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ended June 30, 2026, in compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Haleos Labs Limited has closed its trading window for designated persons and connected persons effective July 1, 2026, to prevent insider trading ahead of its financial results. The restriction will remain in force until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This measure is in accordance with the company's Code of Conduct for Prevention of Insider Trading and Clause 4 of Schedule B of the SEBI (Prohibition of Insider Trading) Regulations 2015.
The closure applies to designated persons, specified connected persons, and their immediate relatives within the company and its subsidiaries. The specific date for the Board meeting to consider the unaudited financial results for the quarter ended June 30, 2026, will be communicated separately in due course.
| Event | Date / Time |
|---|---|
| Trading Window Closure | July 1, 2026 |
| Trading Window Reopens | 48 hours after Q1FY27 results declaration |
| Quarter End | June 30, 2026 |
| Board Meeting Date | To be informed separately |
Historical Stock Returns for Haleos
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.06% | +6.27% | +14.01% | +16.83% | +28.11% | +106.31% |
What market performance does Haleos Labs anticipate for Q1 FY27 that necessitated this early trading window closure?
How might the extended restriction on insiders impact liquidity and trading volume in Haleos Labs shares until the results are released?
Will the upcoming Board meeting address any strategic shifts or business updates alongside the unaudited financial results?






























